Komori
Treasury Stock6090Human Metabolome Technologies,Inc.Information and Communications, Services and Others

Notice Regarding the Decision on Matters Concerning the Acquisition of Treasury Shares

The Board of Directors resolved to acquire up to 250,000 common shares through market purchases, for a maximum total amount of ¥200 million. The acquisition period is from 13 February 2026 to 31 December 2026.

Worth reading
51Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
250000
Shares (maximum)
Wording
Definitive
How definitive the wording is.

Resolution on acquisition limit

Resolved 12 February 2026Market purchases on the Tokyo Stock Exchange
Total acquisition price¥200 million (maximum)
Maximum number of shares to be acquired250,000 shares (maximum)Common shares
4.4%Maximum number that can be acquired

The full horizontal line represents all issued shares, with marks at 10% intervals. The colored section represents the percentage stated in the resolution as the maximum proportion that may be repurchased under it.
This is a limit, and does not mean that the company will buy back all of it. The amount actually acquired will be shown in a later disclosure on the status of the acquisition of treasury shares.

Acquisition period

13 February 2026 to 31 December 2026

Reason for acquisition

キャピタル・アロケーション方針に基づき、株主還元と資本効率の向上及び経営環境の変化に対応した機動的な資本政策の実行を目的として、自己株式の取得を行うものであります。

Reference (number of shares stated in the document)
Current number of treasury shares292,218株(2025年12月31日時点)
Total number of issued shares5,627,579株(自己株式除く、2025年12月31日時点)
Resolution on acquisition limit
ItemDetails
Class of shares to be acquiredCommon shares
Maximum number of shares to be acquired250,000 shares (maximum)
Percentage of total issued shares4.4%
Total acquisition price¥200 million (maximum)
Acquisition period13 February 2026 to 31 December 2026
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Reason for acquisitionキャピタル・アロケーション方針に基づき、株主還元と資本効率の向上及び経営環境の変化に対応した機動的な資本政策の実行を目的として、自己株式の取得を行うものであります。
Resolution date12 February 2026
Current number of treasury shares292,218株(2025年12月31日時点)
Total number of issued shares5,627,579株(自己株式除く、2025年12月31日時点)
Items this document does not state (6)
Number of shares to be retiredPercentage of total issued shares before retirementScheduled retirement dateTotal number of issued shares after retirementChange in acquisition periodChange in acquisition limit

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

キャピタル・アロケーション方針に基づき、株主還元と資本効率の向上及び経営環境の変化に対応した機動的な資本政策の実行を目的として、自己株式の取得を行う。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Decision on Matters Concerning the Acquisition of Treasury Shares | Human Metabolome Technologies,Inc. (6090) timely disclosure | Komori